Life ScienceCompany
Arbor Pharmaceuticals M&A Summary
Arbor Pharmaceuticals has acquired 1 company of its own.
Arbor Pharmaceuticals’ largest acquisition to date was in 2016, when it acquired XenoPort for $467M. Arbor Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Arbor Pharmaceuticals Ownership
Who owns Arbor Pharmaceuticals?
Arbor Pharmaceuticals is owned by Azurity Pharmaceuticals. It was acquired on August 24, 2021.
Was Arbor Pharmaceuticals formerly PE-backed?
Yes. Arbor Pharmaceuticals was formerly owned by 1 private investor.
Arbor Pharmaceuticals Business Overview
Where is Arbor Pharmaceuticals headquartered?
Arbor Pharmaceuticals is headquartered in Atlanta, Georgia.
What sector is Arbor Pharmaceuticals in?
Arbor Pharmaceuticals is a life science company.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Advisors 3